0
Following is a summary of current health news briefs. Boehringer, Zealand's obesity drug did not raise heart risks in trial, data shows Zealand Pharma and Boehringer Ingelheim's experimental obesity
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
